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ABSTRACT 
Background: Postoperative intra-abdominal adhesion is associated with high morbidity 
and mortality. Smad7, a protein that occupies a strategic position in fibrogenesis, inhibits 
the transforming growth factor (TGF) β/Smad signalling pathway. In this study the 
therapeutic potential of exogenous Smad7 in preventing fibrogenesis in postoperative 
intra-abdominal adhesion was investigated. 
Methods: Intra-abdominal adhesion was induced in a rodent model by peritoneal 
abrasion. Smad7 [Author’s response: We have checked that Smad7 has been 
correctly italicized when relating to the Smad7 gene.] was delivered into the peritoneal 
cavity by a non-viral ultrasound–microbubble-mediated naked gene transfection system. 
The effect of Smad7 transgene on adhesion formation was studied by measuring the 
changes of TGF-β, fibrogenic factors, α-SMA, and Smad2/3 activation in the 
anterior abdominal wall. 
Results: Four weeks after surgical abrasion, all rats developed significant peritoneal 
adhesion with enhanced TGF-β expression, increased levels of extracellular matrix 
components and activated myofibroblasts, accompanied by decreased Smad7 expression 
and increased Smad2/3 activation. In rats treated with the Smad7 transgene, the incidence 
and severity of peritoneal adhesion were significantly reduced with biochemical 
downregulation of fibrogenic factors and inhibition of Smad2/3 activation. Serial 
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quantitation using magnetic resonance imaging revealed a significant reduction in 
adhesion areas by 50-70 per cent from day 14 onwards. 
Conclusion: Ultrasound–microbubble-mediated gene transfection is an effective, safe and 
controllable technique that provides timely targeted gene delivery for the treatment of 
postoperative peritoneal adhesions. 
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Introduction 
The development of adhesions is generally considered inevitable after abdominal surgery. 
More than 95 per cent of abdominal operations result in intra-abdominal adhesions, 
although the frequency with which these cause problems is not clear1. Postoperative intra-
abdominal adhesions are associated with bowel obstruction, inadvertent enterotomy at 
adhesiolysis, secondary female infertility, extended operating time and increased 
intraoperative complications in subsequent surgery, and, most importantly, increased 
mortality2. Furthermore, postoperative intra-abdominal adhesions have a huge impact on 
health costs3 and medicolegal litigation4. Various anti-adhesion strategies, including 
laparoscopic surgery, chemical and mechanical separation of bowel loops, and inhibition 
of fibrin deposition or fibroblast proliferation, have been employed to prevent 
postoperative peritoneal adhesion, with limited success5,6. Clinical studies of the efficacy 
of adhesion-limiting agents have been difficult to evaluate because of the inherent 
problem of determining the presence, reduction or absence of adhesions serially within 
the intact abdomen of patients or experimental animals. 
Postoperative adhesions represent exaggerated and dysregulated peritoneal ‘repair’ 
mechanisms in response to trauma, leading to a series of local responses involving acute 
inflammation, extracellular matrix (ECM) deposition, fibrinolysis and neoangiogenesis7,8. 
It is increasingly recognized that the transforming growth factor (TGF) β/Smad signalling 
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pathway plays an important role in the development of fibrosis9. Other than abdominal 
surgery, similar peritoneal adhesions occur following abdominopelvic radiation therapy10. 
Overexpression of Smad7 attenuates the fibrotic effect of TGF-β in renal tubular 
epithelial cells and prevents tissue fibrosis in the kidney11,12. Recently, the authors 
successfully delivered the Smad7 transgene into the peritoneal tissues by a non-viral 
ultrasound–microbubble-mediated system13. In the present study, intraperitoneal gene 
transfer of Smad7 to block the TGF-β/Smad signalling pathway was employed in a 
surgical peritoneal adhesion model, with histological and pathophysiological evaluation 
of this approach, as a potential method of reducing postoperative abdominal adhesion. 
 5
Methods 
Animal model of peritoneal adhesion 
All animal studies were conducted with the approval and guideline of Committee on the 
Use of Live Animals in Teaching and Research of the University of Hong Kong. All 
experiments conformed to the University’s animal care protocols and all surgical 
procedures were conducted under aseptic conditions in the Laboratory Animal Unit. 
A surgically induced abdominal adhesion model was developed in healthy male 
Sprague Dawley rats weighing 200–250 g, using a technique modified from that of Chung 
et al14. In brief, a 3-cm vertical midline incision was made through the abdominal wall 
and peritoneum. Both dorsal and ventral surfaces of the caecum were exposed and 
abraded with a size 15 scalpel blade until blood appeared on the caecal surface. The 
caecum was then placed back into the abdominal cavity in its natural position. The 
parietal peritoneum lateral to the midline incision was also scraped 30 times until 
petechial haemorrhages were observed. Subsequently, the abdominal incision was closed 
in two layers with 4/0 silk sutures. Sham-operated controls were subjected to midline 
incision of the abdomen without any scraping. 
Preparation of naked plasmid DNA 
Mouse Smad7 cDNA with a flag tag (m2) at its amino terminus in pcDNA3 (a gift from 
Dr H. Zhu, Ludwig Institute for Cancer Research, Victoria, Australia) was subcloned into 
 6
a tetracycline-inducible vector, pTRE (Clontech, Palo Alto, California, USA), to obtain 
pTRE–m2Smad7. To achieve doxycycline-induced Smad7 transgene expression, pTRE–
m2Smad7 and an improved pTet-on vector (Clontech), pEFpurop-Tet-on (a gift from Dr G. 
Vario, Cerylid, Melbourne, Australia), were co-transfected into the peritoneal cavity using 
ultrasound-guided delivery. The plasmid DNA obtained from Escherichia coli DH5α 
culture was purified with the Qiagen Plasmid Maxi kit (Qiagen, Valencia, California, 
USA). The identity and purity of the plasmid DNA were confirmed by 1 per cent agarose 
gel electrophoresis before and after digestion with restriction endonucleases. 
Gene transfer of inducible Smad7 into the peritoneal cavity 
Exogenous Smad7 was delivered into the peritoneal cavity via an ultrasound– 
microbubble-mediated system13. Plasmid DNA including an equal amount of pTRE–
m2Smad7 and pEFpurop-Tet-on was dissolved in 0.9 per cent saline. Phospholipid-
stabilized microbubbles (SonoVue®; Bracco Diagnostics, Princeton, New Jersey, USA) 
were gently resuspended before each aliquot was withdrawn. Prepared plasmids and the 
SonoVue® were mixed in ratio of 1 : 1 (vol : vol). Based on the authors’ previous 
studies13, the effect of Smad7 gene transfer is dose dependent, with an optimal dose of 
100 μg per rat. The degree of peritoneal Smad7 expression is also time dependent, with a 
peak on days 2–7, reducing to baseline level on day 14 after ultrasound-mediated gene 
transfer. 
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In this study, 4 ml of the mixed solution containing 100 μg plasmids was injected 
immediately into the abdominal cavity. The ultrasound transducer (Sonitron ® [Author: 
Please advise whether this, or any other product, has ® or TM.][Author’s response: 
Sonitron 1000, which is similar to Sonitron 2000 from the same company, has a 
mark of ® ] 2000; Rich-Mar, Inola, Oklahoma, USA) was applied directly on to the 
abdominal wall with an input frequency of 1 MHz, a 20 per cent duty cycle and an output 
intensity of 2 W/cm2 for a total of 30 s, with 75-s intervals in two cycles. The ultrasound 
probe was moved over the abdominal surface, from the costal margin to the pubic 
symphysis, to ensure that the ultrasound beam reached the whole peritoneum for effective 
delivery of the Smad7 gene to the animal. After the application of ultrasound, Smad7 
transgene expression was induced by 1 ml doxycycline (500 μg/ml; Sigma, St Louis, 
Missouri, USA) via intraperitoneal injection, and continued by administering doxycycline 
200 μg/ml in daily drinking water until the end of the experiment. 
Experimental design 
Animals were randomly divided and treated as follows: group 1, normal sham-operated 
controls (n=8); group 2, surgical abrasion but no other treatment (n=8); group 3, surgical 
abrasion plus ultrasound (n=6); group 4, surgical abrasion plus Smad7 (n=7); group 5, 
surgical abrasion plus ultrasound and Smad7 (n=10); group 6, surgical abrasion plus 
ultrasound and empty vectors with no Smad7 (n=9). In group 5, the treatment was 
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performed on days 1 and 14 after surgery to ensure effective transfection, as a previous 
study had shown that peak gene expression of exogenous Smad7 in peritoneal tissues 
occurred on the second day of transfection and that transgene expression decreased in a 
time-dependent manner13. Rats in groups 3, 4 and 6, serving as treatment controls, 
received the treatment at the same timepoint as animals in group 5, as appropriate. Four 
weeks after operation, animals were killed by anaesthesia for evaluation of adhesions and 
tissue collection. 
Serial determination of peritoneal adhesions was separately studied by a novel 
magnetic resonance imaging (MRI) technique developed recently in the authors’ 
laboratory15, on days 7, 14, 21 and 28 after operation in three additional 
groups:[Editor’s question: Do you mean by “three additional groups” that these 
animals were in addition to the numbers given in the paragraph above?] [Author’s 
response: Yes, these animals were additional to the numbers given in the paragraph 
above] normal sham-operated controls (n=4); adhesion but no treatment (n=6); and 
adhesion treated with ultrasound–microbubble-mediated Smad7 transfection as described 
above (n=6). [Editor’s question: Please clarify whether you are referring to groups 1, 
2 & 5, respectively, as described above.] [Author’s response: These animals were 
additional to the numbers of group 1, 2, & 5.  The results of these animals are 
presented in Figure 2e illustrating the serial measurement of adhesion area by MRI. 
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The method of inducing adhesion and giving Smad7 treatment were “as described 
above”] 
Evaluation of adhesion formation and tissue collection 
Surface areas of peritoneal adhesion were measured serially by abdominal MRI as 
described previously15. In brief, each animal received an intraperitoneal injection of 
prewarmed peritoneal dialysate (0.1 ml/g; Fresenius Medical Care, Bad Homburg, 
Germany) as contrast medium after overnight fasting to reduce intestinal motion during 
MRI. MRI was performed using a small-animal MRI scanner with maximum gradient of 
360 mT/m (70/16 PharmaScan; Bruker BioSpin GmbH, Ettlingen, Germany), operating 
at 7 T. Axial and sagittal gradient echo images were acquired by a multislice flow-
compensated two-dimensional gradient echo sequence with the following parameters: 
repetition time 1 s, echo time 3.5 ms, acquisition matrix 192 × 192, flip angle 30°, field of 
view 6.0 × 6.0 cm, slice thickness 1.0 mm, slice gap 0.5 mm, number of slices 16–22, 
number of averaging 2.  The mean duration for each image was 15 min. The boundary of 
the peritoneal adhesion near the caecum was segmented for each animal in the multislice 
image data set obtained after MRI. The corresponding adhesion area was calculated from 
the estimated length of the adhesion boundary on each slice and the centre-to-centre slice 
spacing by two blinded observers. MRI measurements of adhesion surface areas correlate 
well with laparotomy estimates (R = 0.99)15. 
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After death, the abdomen was opened through a U-shaped incision to prevent any 
disruption of adhesions. Adhesion formation was scored macroscopically on a scale of 0–
4 according to their quantity and intensity by two independent observers. The Yilmaz 
classification was used to grade the adhesion16: grade 0, no adhesion; grade 1, thin 
adhesive bands, easily removable; grade 2, thick adhesive bands limited to one area; 
grade 3: extensive and thick adhesive bands; grade 4: extensive and thick adhesive bands, 
and adhesions between viscera and/or abdominal wall with difficult lysis. Adhesion 
surface area was estimated by measuring the representative lengths according to the shape 
of the adhesion, by two independent observers. 
After evaluation of adhesions, an equal area of tissue was collected from the anterior 
abdominal wall at an identical position in all rats. Part of each tissue was fixed in 10 per 
cent neutral buffered formalin or frozen in optimal cutting temperature medium (Tissue-
Tek®; Sakura Finetek, Torrance, California, USA) for histological and 
immunohistochemical evaluation. The remainder was kept at −70°C for total RNA and 
protein extraction. 
Histology 
After deparaffinization and rehydration, all sections (5-μm thick) of the anterior 
abdominal wall were stained with a modified Gomori’s trichrome stain kit (Biocare 
Medical, Walnut Creek, California, USA). The peritoneal sections were examined in a 
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blinded manner and the thickness (in micrometers) of the submesothelial layer at five 
random locations was measured. Haematoxylin and eosin staining was also performed to 
evaluate inflammation in the anterior abdominal wall. 
Immunofluorescence and immunohistochemistry staining 
Immunohistochemical analysis and immunofluorescence staining (for determination of 
flag m2 protein, TGF-β, α-smooth muscle actin, collagen I, collagen III and fibronectin) 
in the abdominal wall were performed using paraffin-embedded or frozen sections as 
appropriate17. The bound antibodies were detected by means of Dako Envision Plus kits 
(Dako, Carpinteria, California, USA) or FITC-conjugated antimouse antibodies as 
appropriate. 
RNA isolation and reverse transcriptase–polymerase chain reaction 
RNA extraction and RT–PCR were performed as described previously17. The primer 
sequences for amplifying the target genes, the Genebank accession number and their 
product sizes are as follows: rat collagen I (Z78279, 469 bp), 5′-
TGCCGTGACCTCAAGATGTG-3′ (forward) and 5′-CACAAGCGTGCTGTAGGTGA-
3′ (reverse); rat collagen III (NM_032085, 482 bp), 5′-
CTGGACCAAAAGGTGATGCTG-3′ (forward) and 5′-
TGCCAGGGAATCCTCGATGTC-3′ (reverse); rat fibronectin (NM_019143, 320 bp), 5′-
GAAGTGGTTCATGCCGATCA-3′ (forward) and 5′-TCCAGCCCTGTAACTGTGTA-3′ 
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(reverse); rat α-smooth muscle action (α-SMA) (J02781, 101 bp), 5′-
AAGAGGAAGACAGCACAGCTC-3′ (forward) and 5′-GAT 
GGATGGGAAAACAGCC-3′ (reverse); rat Smad2 (AF056001, 477 bp), 5′-
CACAAGCGTGCTGTAGGTGA-3′ (forward) and 5′-CACTATCACTTAGGCACTCG-3′ 
(reverse); rat TGF-β1 (NM_021578, 301 bp), 5′-GCAACAACGCAATCTATGAC-3′ 
(forward) and 5′-CCCTGTATTCCGTCTCCTT-3′ (reverse); and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (AB017801, 837 bp), 5′-
ACCCCTTCATTGACCTCAACT-3′ (forward) and 5′-
ACCAGGAAATGAGCTTCACAAA -3′ (reverse). GAPDH served as an internal control. 
The PCR product yielded was expressed as a ratio to the GAPDH amplicon. 
Real-time polymerase chain reaction for Smad7 mRNA quantification 
After total RNA extraction, cDNA was synthesized from DNase-treated total RNA (2 μg) 
in 20-μl reactions using the Superscript II reverse transcriptase kit (Invitrogen, Carlsbad, 
California, USA) and stored at −20°C until use. Smad7 qPCR primers used were: 5′-
CCAACTGCAGACTGTCCAGA-3′ (forward) and 5′-TTCTCCTCCCAGTATGCCAC-3′ 
(reverse); GAPDH qPCR primers were: 5′-TGCCACTCAGAAGACTGTGG-3′ (forward) 
and 5′-GGATGCAGGGATGATGTTCT-3′ (reverse). Real-time PCR reactions were 
carried out in an ABI Prism 7500 Sequence Detection system using the SYBR-Green 
reaction kit (Applied Biosystems, Foster City, California, USA). For quantification, 
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GAPDH mRNA served as an endogenous control. The ΔΔCt method was used to 
calculate the results. 
Western blot analysis 
Tissue from the anterior abdominal wall was ground and homogenized in a lysis buffer 
before subjecting to western blot analysis with specific antibodies, as described 
previously17. The primary antibodies included mouse monoclonal antibodies to actin 
(1 : 2000; Lab Vision Corporation, Fremont, California, USA), α-SMA (1 : 2000; Dako) 
and fibronectin (1 : 1000; Fitzgerald Industries, Concord, Massachusetts, USA), goat 
polyclonal antibodies to pSmad2/3 (1 : 600), rabbit polyclonal antibodies to Smad2 and 
TGF-β1 (1 : 600; Santa Cruz Biotechnology, Santa Cruz, California, USA), collagen I 
(1 : 20 000) and collagen III (1 : 10 000; Fitzgerald Industries). The secondary antibodies 
included a 1 : 20 000 dilution of horseradish peroxidase-conjugated swine antigoat (for 
pSmad2/3), a 1 : 30 000 dilution of goat antimouse (for actin, α-SMA and fibronectin) 
and a 1 : 2000 dilution of goat antirabbit (for collagen I, collagen II, TGF-β1 and Smad2) 
antibodies (Dako). Densitometry results were reported as a ratio to the actin signal. 
Statistical analysis 
Data for Smad7 expression in the peritoneum were expressed as mean (s.d.) and analysed 
by Tukey's multiple comparison test. The results of fibrogenic factors and the thickness of 
the submesothelial layer of peritoneum were expressed as median (interquartile range) 
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and analysed by non-parametric methods. Differences in these parameters between the 
study groups were compared with the Kruskal–Wallis test, and differences between 
individual groups with the Mann–Whitney U test. Differences in MRI-measured 
adhesion area between adhesions with no treatment and Smad7-treated groups were 
compared with t-test. Correlations between MRI-measured adhesion area and 
laparotomy estimation, as well as bodyweight, were evaluated with Pearson’s correlation 
test. P < 0.050 was considered statistically significant. Analyses were performed with the 
statistical package SPSS® version 12.0 (SPSS, Chicago, Illinois, USA). 
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Results (Editor’s remark: I am conscious that there are a lot of Figures in your 
manuscript. Where possible, text and illustration should be complementary rather 
than merely duplicative. For this reason, I suggest that we omit the histology 
pictures (Figs 3 a-c) and the immunohistochemistry (Figs 5 a-c) and simply retain 
the text. Please confirm that you would be happy with these changes. Adjust the 
numbering of subsequent figures accordingly.) [Author’s response: Figs 3 and Figs 5 
were omitted as you suggested. We would be happy with these changes. The 
numbering of subsequent figures has been adjusted (in bold).] 
Smad7 transfection rate and transgene expression in the peritoneum 
After the delivery of Smad7 transgene, expression of Smad7 was upregulated in the 
abdominal wall of animals treated with the ultrasound–microbubble-mediated gene 
delivery compared with that in animals without Smad7 transfection (Fig. 1a). Smad7 was 
localized mainly in the mesothelial and submesothelial layers of the peritoneum. 
Transfection mediated by ultrasound was more efficient than that without ultrasound 
exposure (P<0.001). Immunofluorescence studies using antiflag m2 antibody revealed 
marked staining of Smad7 protein in rats receiving Smad7 transfection, whereas no signal 
was detected in no-transfection groups (Fig. 1b). Ultrasound significantly increased the 
protein synthesis of Smad7 in the peritoneum compared with that in animals receiving no 
ultrasonic exposure. 
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Effect of Smad7 transgene on peritoneal adhesion formation 
After death, peritoneal adhesion was graded macroscopically (Fig. 2a). The incidence and 
severity of postoperative adhesions in the various groups of experimental animals are 
summarized in Table 1. Following peritoneal abrasion, all eight rats that received 
adhesion alone (group 2) developed peritoneal adhesions, with grade 4 severity in seven 
and grade 3 severity in one animal. The percentage and severity were greatly reduced in 
animals that received ultrasound-mediated Smad7 transfection (P<0.001 versus group 2). 
Despite the development of grade 4 adhesions in only three of the seven rats receiving 
Smad7 alone (group 4), this proportion was not significantly different to that for group 2 
animals (P=0.094). Rats receiving ultrasound alone or empty vectors showed no 
improvement in adhesion formation. 
Using a novel MRI technique developed recently in the authors’ laboratory15, In 
normal rats, the caecum moved and floated within the abdominal cavity on MRI (Fig. 2b). 
In animals with adhesions (group 2), the caecum adhered to the anterior abdominal wall 
with no motion, and there was no contrast medium between the adhesive caecum and the 
anterior abdominal wall (Fig. 2c); adhesion was less marked in rats treated with Smad7 
(Fig. 2d). The surface area of peritoneal adhesions was serially and quantitatively 
evaluated by MRI in (Fig. 2e). Peritoneal adhesions developed after the abdominal 
operation and progressed gradually until death. Rats treated with Smad7 showed a 
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decrease in adhesion area by 44.3, 47.7, and 43.6 per cent at 14, 21, and 28 days after 
operation, respectively compared with that in animals having no treatment at the same 
time point (P=0.012, 0.007, 0.022 at day 14, 21 and 28 after operation, respectively.   
MRI-determined adhesion areas before killing correlated well with evaluations at 
laparotomy in rats with peritoneal adhesions (r=0.97, P<0.001). Although rats grew 
during the observation period, no correlation was found between body weight and the 
surface area of peritoneal adhesions. 
Effect of Smad7 transgene on morphological changes in the peritoneum 
Histological sections of the anterior abdominal wall from normal rats demonstrated a thin 
submesothelial compact zone with a mesothelial monolayer (Fig. 3a,b). When adhesion 
occurred (group 2), the caecal smooth muscle was fused to the abdominal striated muscle 
with a markedly thickened submesothelial compact zone. In the Smad7-treated group, the 
abraded abdominal wall exhibited a thickened submesothelial layer with increased 
collagen deposition compared with peritoneum from normal control animals, but with no 
adhesion to the caecum. In addition, increased cellular infiltration of neutrophils and 
lymphocytes, as seen in group 2, was not observed in the submesothelial layer of 
peritoneum in animals receiving Smad7 transfection (Fig. 3c). 
Rats with surgically induced peritoneal adhesions had an increased thickness of the 
submesothelial compact zone of the abdominal wall compared with normal controls 
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(median 300 (range 150–800) versus 50 (40–100) μm respectively; P<0.001). The 
thickness of the submesothelial compact zone was reduced in the ultrasound-mediated 
Smad7 transfection group (group 5: median 95 [range 50–300 μm]) and in the Smad7 
alone group (group 4: median 200 [range 100–650 μm)) (both P<0.001 versus adhesion 
but no treatment). This reduction in submesothelial thickness by Smad7 transfection was 
more significant with ultrasound (P<0.001 versus Smad7 transfection without ultrasound). 
In contrast, no significant reduction in submesothelial thickness was observed in rats 
receiving either ultrasound alone (median 400 [range 120–750 μm]) or empty vectors 
(median 300 [80–800 μm]) compared with the adhesion group receiving no treatment. 
Effect of Smad7 transgene on extracellular matrix formation in the peritoneum 
Both gene expression and protein synthesis of fibrogenic factors, including collagens I 
(Fig. 3a,b), collagen III (Fig. 3c,d) and fibronectin (Fig. 3e,f), were increased markedly in 
the submesothelial compact zone of the abdominal wall of rats with surgical adhesions 
compared with normal controls. Similarly, in peritoneal tissues the expression of α-SMA, 
a marker for myofibroblasts in ECM, was increased significantly in rats with adhesions 
(Fig. 3g,h). The formation of these ECM components in the peritoneum was reduced in 
rats treated with ultrasound-mediated Smad7 transfection compared with that in animals 
receiving no treatment, ultrasound alone or empty vectors. Immunohistochemical studies 
confirmed increased levels of collagen I (Fig. 5a), collagen III and fibronectin (data not 
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shown), as well as α-SMA (Fig. 5b) in the submesothelial compact zone of the abraded 
peritoneum with or without adhesions. 
Effect of Smad7 transgene on transforming growth factor β/Smad signalling 
Compared with normal controls, both gene expression and protein synthesis of TGF-β 
were upregulated in the abdominal wall of rats with peritoneal adhesions (Fig. 4). 
Immunohistochemical studies confirmed increased levels of TGF-β in the submesothelial 
compact zone of the abdominal wall with the development of postoperative adhesions. 
The level of TGF-β was reduced in rats receiving ultrasound-mediated Smad7 transfection. 
The mRNA expression of Smad2 and the phosphorylated Smad2/3 protein increased 
significantly in the abdominal wall of rats with adhesions compared with that in normal 
controls (Fig. 5a,c), despite no significant change in protein synthesis of Smad2 (Fig. 5b). 
These findings indicate that the TGF-β/Smad signalling pathway was activated when the 
peritoneum was damaged by surgical abrasion. More importantly, phosphorylated 
Smad2/3 expression was decreased in rats receiving ultrasound–microbubble-mediated 
Smad7 transfection, but not in those receiving Smad7 alone, ultrasound alone or empty 
vectors (Fig. 5c). 
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Discussion 
This study has demonstrated that exogenous Smad7 reduced TGF-β expression, 
myofibroblast activation and ECM deposition in the peritoneum. Most importantly, the 
Smad7 transgene blocked Smad2/3 activation in the injured peritoneum, thereby 
preventing peritoneal adhesion formation. 
Peritoneal adhesions develop in a large proportion of patients undergoing 
laparotomy (75–90 per cent) or laparoscopic surgery (13–44 per cent)18,19. This poses a 
major burden on clinical safety, health costs and medical litigation. Numerous materials, 
including membrane or gel barriers, dextran, hyaluronic acid and fibrinolytic agents have 
been examined for their ability to prevent the formation of postoperative adhesions with 
limited success20. The latest randomized controlled trial failed to demonstrate any 
therapeutic value for a sodium hyaluronate-based bioresorbable membrane21. Another 
randomized double-blind study showed only a 10 per cent reduction in de novo adhesion 
incidence with icodextrin (a corn starch polymer solution), which failed to prevent 
adhesion formation in half of the patients22. 
An understanding of the pathophysiological mechanisms of adhesion formation is 
essential for developing effective preventive methods. At least three mechanisms operate 
in adhesion formation: mesothelial injury, local inflammation, and imbalance of 
fibrinolytic and fibrogenic activities23. Their pivotal role is suggested by experimental 
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observations that peritoneal adhesion is attenuated by enhancing proliferation and 
migration of mesothelial cells24, by suppressing T cell-induced neutrophil aggregation14 
and by neutralizing the effect of fibrogenic factors such as TGF-β25. 
In this study, the role of the TGF-β/Smad signalling pathway in the pathogenesis of 
peritoneal adhesion was explored. To preserve the integrity of the parietal peritoneum, 
peritoneal abrasion was performed rather than excision of a section of anterior abdominal 
wall26. The incidence and severity of adhesions was increased by scraping both parietal 
and visceral peritoneum instead of scratching either tissue alone27. The injured surfaces 
were left disjoined without sutures to enable adhesion development under natural 
conditions and to allow normal movement of organs or peristalsis within the peritoneal 
cavity, rather than apposing the injured peritoneal surfaces with mattress 
sutures28.[Author’s response: This last sentence, as amended, is fine] All animals that 
underwent this technique of peritoneal abrasion developed peritoneal adhesions with 
high-grade severity. An increase in ECM deposition, activation of myofibroblasts and 
Smad2/3, and TGF-β expression was observed in the injured peritoneal tissue. The study 
further confirmed the key role of TGF-β in stimulating myofibroblast activation and 
enhanced ECM formation in the development of peritoneal adhesions29–31. Interestingly, 
increased Smad2 mRNA and phosphorylated Smad2/3 protein was also observed in the 
injured peritoneum, demonstrating activation of the TGF-β/Smad signalling pathway. 
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Smad7, an inhibitory Smad, prevents the phosphorylation of Smad2 and Smad3, and 
then disrupts their nuclear translocalization, thereby inhibiting TGF-β signal transduction 
by a negative feedback loop32. Overexpression of Smad7 attenuates the fibrotic effect of 
TGF-β and thus prevents tissue fibrosis in the kidney11,12. Recently, the authors 
successfully delivered the Smad7 transgene into peritoneal tissues by a non-viral 
ultrasound–microbubble-mediated system13. They detected less than 10 per cent apoptotic 
cells and no inflammatory reaction in peritoneal tissues following this transfection, with 
high transfection efficiency in peritoneal tissues (approximately 80 per cent)17. The 
technique is simple and avoids the potential immunogenicity and mutagenesis that may be 
associated with viral gene therapy. The peak of transgene expression occurred 2 days after 
transfection, and transgene expression diminished in a time-dependent manner over 2 
weeks. Importantly, intraperitoneal gene delivery using Tet-on inducible vector via the 
ultrasound–microbubble-mediated system is safe and controllable. Histological 
examination showed that this method did not elicit any local inflammatory reactions or 
cytotoxicity caused by viral vectors, as reported recently13. Moreover, the duration of 
transgene expression can be regulated by repeated administration via the peritoneal route. 
This promising technique of gene delivery is ideal for treating postoperative adhesions in 
which the dynamic and complex dysregulated repair process begins at 4–7 days and lasts 
for the first 2 weeks after trauma to the peritoneum23. 
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Various resident cells in the peritoneum are implicated in early and late events that 
lead to inflammatory and fibrotic responses during the process of peritoneal insult. 
Proinflammatory cytokines derived from activated T cells induce a rapid but transient 
influx of neutrophils followed by accumulation of macrophage associated with injury of 
mesothelial cells14. Peritoneal mesothelial cells and macrophages are actively involved in 
peritoneal inflammation and fibrosis via TGF-β33,34. Overexpression of Smad7 in T cells 
has been shown to prevent a murine model of glomerulonephritis by suppressing multiple 
effects of TGF-β35. As the signalling receptors TGF-βR type I and TGF-βR type II are 
expressed on T cells36, TGF-β signalling in T cells is likely to be involved in T cell-
mediated cell responses during the development of peritoneal adhesion. Hence, 
overexpression of Smad7 may downregulate the activation of these peritoneal resident 
cells by inhibiting the TGF-β/Smad signalling pathway. Unlike TGF-β, which exhibits 
diverse effects on fibrosis and inflammation, Smad7, despite induction by TGF-β, has 
unique roles in antifibrosis by blocking TGF-β signalling (including its downstream 
mediator, connective tissue growth factor) and in anti-inflammation by inhibiting nuclear 
factor κB activation37. These findings signify the strategic role and therapeutic value of 
Smad7 in inhibiting the TGF-β/Smad signal transduction involved in the development of 
postoperative peritoneal adhesions. 
 Interestingly, Smad7–microbubbles without ultrasound exposure partially inhibited 
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the production of fibrogenic factors and attenuated peritoneal adhesion. It is possible that 
microbubbles preferentially adhere to the disrupted vascular endothelium and to activated 
leucocytes and monocytes that are recruited along injured endothelial cells38.  In the 
present model, microbubbles selectively concentrating at the damaged endothelium may 
collapse locally and release the preincorporated DNA. However, the efficiency of Smad7 
transfection without ultrasound was lower than that with ultrasound, signifying the role of 
ultrasound in enhancing the transfection efficiency. In addition, ultrasound alone exerted 
no inhibitory effect on adhesion formation, indicating that ultrasound per se has no direct 
therapeutic effect on adhesion formation. 
By extending the previous observation that peritoneal MRI permits the delineation of 
peritoneal dialysis-related pathological conditions in patients undergoing peritoneal 
dialysis39, the authors developed a novel MRI technique that enables an objective and 
serial quantitation of intra-abdominal adhesions with good correlation to laparotomy 
measurement15. In the present study, the effect of Smad7 transfection was monitored by 
serial measurement of adhesion areas, and Smad7 was found significantly to reduce 
adhesion formation from day 14 onwards by two-fold. Emerging evidence has 
demonstrated that high spatial resolution MRI can be applied successfully in functional 
studies in vivo by depicting the recruitment of macrophages in inflamed soft-tissue 
infection using the magnetic contrast agent, iron oxide particles40. It would be interesting 
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further to investigate MRI of macrophages as non-invasive markers for early functional 
changes in peritoneal adhesion. 
This novel therapeutic approach may prevent or reduce postoperative abdominal 
adhesions in a clinical setting. Although the treatment is at an early and experimental 
stage with improvements possible (such as replacing the doxycycline-driven 
promoter)13,41, non-viral ultrasound–microbubble-mediated naked gene transfection may 
be an effective, safe and controllable technique permitting timely targeted gene delivery 
for the prevention of postoperative peritoneal adhesions.  
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Fig. 1 Expression of Smad7 mRNA and protein in the peritoneum. a Quantification of 
Smad7 mRNA expression in the abdominal wall by real-time reverse transcriptase–
polymerase chain reaction. Values are mean(s.d.), expressed as fold change relative to 
normal controls. b Representative immunofluorescence for flag-tagged exogenous Smad7 
in the abdominal wall (original magnification ×100). Group 1, sham-operated controls; 
group 2, adhesion but no other treatment; group 3, adhesion plus ultrasound; group 4, 
adhesion plus Smad7; group 5, adhesion plus ultrasound and Smad7; group 6, adhesion 
plus ultrasound and empty vectors with no Smad7. *P<0.050, †P<0.001 versus groups 1, 













Fig. 2 Evaluation of peritoneal adhesion by macroscopic examination and magnetic 
resonance imaging (MRI). a Grading of peritoneal adhesion by macroscopic examination. 
b–d Representative magnetic resonance images through the peritoneal cavity and 
corresponding macroscopic examination on day 28. Asterisks (*) indicate the caecum, 
and arrows denote peritoneal adhesions. e Serial changes in adhesion area by MRI. Values 
















Fig. 3 Morphological appearance of normal peritoneum, abraded peritoneum with Smad7 
treatment, and abraded peritoneum with no treatment. a Haematoxylin and eosin stain; b 
trichrome stain (original magnification ×50). Arrows indicate the caecal mucosa. c 
Haematoxylin and eosin stain (original magnification ×200)(Author’ response: agree to 
omit) 
 
Fig. 3 Gene expression and protein synthesis of extracellular matrix components in the 
anterior abdominal wall. Gene expression of a collagen I, c collagen III, e fibronectin and 
g α-smooth muscle actin (α-SMA). Protein synthesis of b collagen I, d collagen III, f 
fibronectin and h α-SMA. Boxes show median values with interquartile ranges, and error 
bars denote tenth and 90th percentiles. Group 1, sham-operated controls; group 2, 
adhesion but no other treatment; group 3, adhesion plus ultrasound; group 4, adhesion 
plus Smad7; group 5, adhesion plus ultrasound and Smad7; group 6, adhesion plus 
ultrasound and empty vectors with no Smad7. GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase. *P<0.050, †P<0.010, ‡P<0.001 versus group 1; §P<0.050, ¶P<0.010 






Fig. 5 Representative immunohistochemical staining for a collagen I, b α-smooth muscle 
action and c transforming growth factor β in normal, abraded and adhesive peritoneum 
(original magnification ×50) (Author’ response: agree to omit) 
 
Fig. 4 a Gene expression and b protein synthesis of transforming growth factor (TGF) β 
in the anterior abdominal wall. Boxes show median values with interquartile ranges, and 
error bars denote tenth and 90th percentiles. Group 1, sham-operated controls; group 2, 
adhesion but no other treatment; group 3, adhesion plus ultrasound; group 4, adhesion 
plus Smad7; group 5, adhesion plus ultrasound and Smad7; group 6, adhesion plus 
ultrasound and empty vectors with no Smad7. GAPDH, glyceraldehyde-3-phosphate 











Fig. 5 Activation of Smad2/3 in the anterior abdominal wall. a Gene expression of Smad2; 
b protein synthesis of Smad2; c protein synthesis of phosphorylated Smad2/3. Boxes 
show median values with interquartile ranges, and error bars denote tenth and 90th 
percentiles. Group 1, sham-operated controls; group 2, adhesion but no other treatment; 
group 3, adhesion plus ultrasound; group 4, adhesion plus Smad7; group 5, adhesion plus 
ultrasound and Smad7; group 6, adhesion plus ultrasound and empty vectors with no 
Smad7. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. *P<0.050, †P<0.010, 
‡P<0.001 versus group 1; §P<0.010 versus group 2 (Mann-Whitney U-test) 
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Table 1 Adhesion formation in 48 experimental animals at 28 days 
 Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 
Grade (n=8) (n=8) (n=6) (n=7) (n=10) (n=9) 
0 8   3 7  
1     2  
2    1  1 
3  1 1  1  
4  7 5 3  8 
Group 1, sham-operated controls; group 2, adhesion but no other treatment; group 3, 
adhesion plus ultrasound; group 4, adhesion plus Smad7; group 5, adhesion plus 
ultrasound and Smad7; group 6, adhesion plus ultrasound and empty vectors with no 
Smad7. 
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